Abstract
Stroke is the third leading cause of death in the United States with over 783,000 strokes reported annually.1 Over one-third of patients die and another one-third are severely disabled.The annual economic cost exceeds $30 billion.2 Randomized trials have established the efficacy of carotid endarterectomy (CEA) in the prevention of stroke for patients with high-grade carotid stenosis (CS).3–7 The advent of newer technologies and a desire for less invasive treatment have encouraged investigators to propose carotid artery stenting (CAS) as an alternative to CEA.1,8–10 Our institution1, 8,11–17 (Figure 10–1), along with others,18–22 has demonstrated that CAS is technically feasible and safe in patients with restenosis after CEA, surgically inaccessible lesions, previous radiation, or significant medical comorbidities. The 30-day stroke and death rate in 190 CAS procedures at our institution was 4.15%, indicating a competitive alternative to CEA.14 However, due to the proven efficacy of CEA, current indications for CAS have been limited to situations where CEA yields suboptimal results.13,23
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lal BK, Hobson IR. Carotid artery occlusive disease. Curr Treat Options Cardiovasc Med 2000;2(3):243–54.
Matcher DB, Duncan PW. Cost of Stroke. Stroke Clin Updates 1994;5:9–12.
Hobson RW 2nd, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med 1993;328(4):221–7.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325(7):445–53.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421–8.
Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339(20):1415–25.
Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004;363(9420):1491– 502.
Hobson RW 2nd, Goldstein JE, Jamil Z, et al. Carotid restenosis: Operative and endovascular management. J Vasc Surg 1999;29(2):228–35; discussion 35–8.
Dorros G. Complications associated with extracranial carotid artery interventions. J Endovasc Surg 1996;3(2): 166–70.
Ferguson RD, Ferguson JG. Carotid angioplasty. In search of a worthy alternative to endarterectomy. Arch Neurol 1996;53(7):696–8.
Hobson RW 2nd, Lal BK, Chakhtoura E, et al. Carotid artery stenting:Analysis of data for 105 patients at high risk. J Vasc Surg 2003;37(6):1234–9.
Hobson RW 2nd, Lal BK, Chakhtoura EY, et al. Carotid artery closure for endarterectomy does not influence results of angioplasty-stenting for restenosis. J Vasc Surg 2002; 35(3):435–8.
Lal BK, Hobson RW 2nd, Goldstein J, et al. In-stent recurrent stenosis after carotid artery stenting: Life table analysis and clinical relevance. J Vasc Surg 2003;38(6):1162–8; discussion 9.
Cuadra S, Hobson R, Lal B, et al. Carotid artery stenting: Does the outcome depend on the indication? Abstract presented at the Vascular 2005, Annual conference of the Society for Vascular Surgery, Society for Vascular Technology, and Society for Vascular Medicine and Biology, Chicago, IL, 2005.
Choi HM, Hobson RW, Goldstein J, et al. Technical challenges in a program of carotid artery stenting. J Vasc Surg 2004;40(4):746–51; discussion 51.
Hobson RW 2nd. Carotid artery stenting. Surg Clin North Am 2004;84(5):1281–94, vi.
Lal BK, Hobson RW 2nd, Goldstein J, Chakhtoura EY, Duran WN. Carotid artery stenting: Is there a need to revise ultrasound velocity criteria? J Vasc Surg 2004;39(1):58–66.
Al-Mubarak N, Roubin GS, Vitek JJ, New G, Iyer SS. Procedural safety and short-term outcome of ambulatory carotid stenting. Stroke 2001;32(10):2305–9.
Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis. Circulation 2001;103(4):532–7.
Vitek JJ, Roubin GS, New G, Al-Mubarek N, Iyer SS. Carotid angioplasty with stenting in post-carotid endarterectomy restenosis. J Invasive Cardiol 2001;13(2):123–5; discussion 58–70.
Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000;50(2):160–7.
Ohki T, Veith FJ. Carotid artery stenting: Utility of cerebral protection devices. J Invasive Cardiol 2001;13(1): 47–55.
Veith FJ, Amor M, Ohki T, et al. Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. J Vasc Surg 2001;33(2 Suppl): S111–6.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351(15):1493–501.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 2001;357(9270):1729–37.
Hobson RW 2nd. Update on the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) protocol. J Am Coll Surg 2002;194(1 Suppl):S9–14.
Hobson RW 2nd, Howard VJ, Roubin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004;40(6):1106– 11.
Willfort-Ehringer A, Ahmadi R, Gruber D, et al. Arterial remodeling and hemodynamics in carotid stents:A prospective duplex ultrasound study over 2 years. J Vasc Surg 2004;39(4):728–34.
Alexandrov AV, Brodie DS, McLean A, Hamilton P, Murphy J, Burns PN. Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke 1997;28(2):339–42.
Faught WE, Mattos MA, van Bemmelen PS, et al. Colorflow duplex scanning of carotid arteries: New velocity criteria based on receiver operator characteristic analysis for threshold stenoses used in the symptomatic and asymptomatic carotid trials. J Vasc Surg 1994;19(5):818–27; discussion 27–8.
Robbin ML, Lockhart ME, Weber TM, et al. Carotid artery stents: Early and intermediate follow-up with Doppler US. Radiology 1997;205(3):749–56.
Ringer AJ, German JW, Guterman LR, Hopkins LN. Follow-up of stented carotid arteries by Doppler ultrasound. Neurosurgery 2002;51(3):639–43; discussion 43.
Wilson KA, Hoskins PR, Lee AJ, Fowkes FG, Ruckley CV, Bradbury AW. Ultrasonic measurement of abdominal aortic aneurysm wall compliance: A reproducibility study. J Vasc Surg 2000;31(3):507–13.
Green JF. Mechanical Concepts in Cardiovascular and Pulmonary Physiology, 2nd ed. Philadelphia, PA: Lea & Febiger, 1977.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Lal, B.K., Hobson, R.W. (2010). Duplex Ultrasound Velocity Criteria for Carotid Stenting Patients. In: AbuRahma, A.F., Bergan, J.J. (eds) Noninvasive Cerebrovascular Diagnosis. Springer, London. https://doi.org/10.1007/978-1-84882-957-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-84882-957-2_10
Publisher Name: Springer, London
Print ISBN: 978-1-84882-956-5
Online ISBN: 978-1-84882-957-2
eBook Packages: MedicineMedicine (R0)